Finland vs North Macedonia: The number of people with susceptibility test result for rifampicin
Finland
87
in 2021
North Macedonia
100
in 2021
Finland rank
111th
North Macedonia rank
109th
The number of people with susceptibility test result for rifampicin over time
- Finland
- North Macedonia
How they compare
North Macedonia currently reports 100 against 87 in Finland, a difference of 13.
That makes North Macedonia's figure about 1.1 times Finland's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was North Macedonia ahead.
Finland ranks 111th and North Macedonia ranks 109th of 155 countries.
Across the 2 decades both report, Finland averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Finland | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 127.33 | 130 | 2.67 | North Macedonia |
| 2020s | 93.5 | 90.5 | 3 | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Finland or North Macedonia?
- North Macedonia, at 100 against 87 in Finland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Finland and North Macedonia?
- 13, with North Macedonia ahead.
- How many years of comparable data are there for Finland and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Finland and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Finland ranks 111th and North Macedonia ranks 109th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.